|
1
|
Linggi B and Carpenter G: ErbB receptors:
new insights on mechanisms and biology. Trends Cell Biol.
16:649–656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yarden Y and Sliwkowski MX: Untangling the
ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohgaki H and Kleihues P: Population-based
studies on incidence, survival rates, and genetic alterations in
astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol.
64:479–489. 2005.PubMed/NCBI
|
|
4
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hatanpaa KJ, Burma S, Zhao D and Habib AA:
Epidermal growth factor receptor in glioma: signal transduction,
neuropathology, imaging, and radioresistance. Neoplasia.
12:675–684. 2010.PubMed/NCBI
|
|
6
|
Lopez-Gines C, Gil-Benso R, Ferrer-Luna R,
et al: New pattern of EGFR amplification in glioblastoma and
the relationship of gene copy number with gene expression profile.
Mod Pathol. 23:856–865. 2010.
|
|
7
|
Bredel M, Scholtens DM, Yadav AK, et al:
NFKBIA deletion in glioblastomas. N Engl J Med. 364:627–637.
2011. View Article : Google Scholar
|
|
8
|
Veselska R, Skoda J, Loja T, et al: An
unusual loss of EGFR gene copy in glioblastoma multiforme in
a child: a case report and analysis of a successfully derived
HGG-02 cell line. Childs Nerv Syst. 26:841–846. 2010.
|
|
9
|
Loja T, Chlapek P, Kuglik P, Pesakova M,
Oltova A, Cejpek P and Veselska R: Characterization of a GM7
glioblastoma cell line showing CD133 positivity and both
cytoplasmic and nuclear localization of nestin. Oncol Rep.
21:119–127. 2009.PubMed/NCBI
|
|
10
|
Clark PA, Iida M, Treisman DM, et al:
Activation of multiple ERBB family receptors mediates glioblastoma
cancer stem-like cell resistance to EGFR-targeted inhibition.
Neoplasia. 14:420–428. 2012.PubMed/NCBI
|
|
11
|
Gry M, Rimini R, Strömberg S, Asplund A,
Pontén F, Uhlén M and Nilsson P: Correlations between RNA and
protein expression profiles in 23 human cell lines. BMC Genomics.
10:3652009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang P, Steck PA and Yung WK: The
autocrine loop of TGF-α/EGFR and brain tumors. J Neurooncol.
35:303–314. 1997.
|
|
13
|
Ekstrand AJ, James CD, Cavenee WK, Seliger
B, Pettersson RF and Collins VP: Genes for epidermal growth factor
receptor, transforming growth factor α, and epidermal growth factor
and their expression in human gliomas in vivo. Cancer Res.
51:2164–2172. 1991.
|
|
14
|
Stommel JM, Kimmelman AC, Ying H, et al:
Coactivation of receptor tyrosine kinases affects the response of
tumor cells to targeted therapies. Science. 318:287–290. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hutterer M, Knyazev P, Abate A, et al: Axl
and growth arrest-specific gene 6 are frequently overexpressed in
human gliomas and predict poor prognosis in patients with
glioblastoma multiforme. Clin Cancer Res. 14:130–138. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Linger RM, Keating AK, Earp HS and Graham
DK: TAM receptor tyrosine kinases: biologic functions, signaling,
and potential therapeutic targeting in human cancer. Adv Cancer
Res. 100:35–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rogers AE, Le JP, Sather S, Pernu BM,
Graham DK, Pierce AM and Keating AK: Mer receptor tyrosine kinase
inhibition impedes glioblastoma multiforme migration and alters
cellular morphology. Oncogene. 31:4171–4181. 2012. View Article : Google Scholar
|
|
18
|
Wang Y, Moncayo G, Morin P Jr, et al: Mer
receptor tyrosine kinase promotes invasion and survival in
glioblastoma multiforme. Oncogene. 32:872–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Velpula KK, Dasari VR, Asuthkar S,
Gorantla B and Tsung AJ: EGFR and c-Met cross talk in glioblastoma
and its regulation by human cord blood stem cells. Transl Oncol.
5:379–392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kong DS, Song SY, Kim DH, et al:
Prognostic significance of c-Met expression in glioblastomas.
Cancer. 115:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joo KM, Jin J, Kim E, et al: MET signaling
regulates glioblastoma stem cells. Cancer Res. 72:3828–3838. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eckerich C, Schulte A, Martens T, Zapf S,
Westphal M and Lamszus K: RON receptor tyrosine kinase in human
gliomas: expression, function, and identification of a novel
soluble splice variant. J Neurochem. 109:969–980. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harel L, Costa B and Fainzilber M: On the
death Trk. Dev Neurobiol. 70:298–303. 2010.PubMed/NCBI
|
|
24
|
Wadhwa S, Nag TC, Jindal A, Kushwaha R,
Mahapatra AK and Sarkar C: Expression of the neurotrophin receptors
Trk A and Trk B in adult human astrocytoma and glioblastoma. J
Biosci. 28:181–188. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hansen K, Wagner B, Hamel W, Schweizer M,
Haag F, Westphal M and Lamszus K: Autophagic cell death induced by
TrkA receptor activation in human glioblastoma cells. J Neurochem.
103:259–275. 2007.PubMed/NCBI
|
|
26
|
Dadakhujaev S, Noh HS, Jung EJ, Hah YS,
Kim CJ and Kim DR: The reduced catalase expression in TrkA-induced
cells leads to autophagic cell death via ROS accumulation. Exp Cell
Res. 314:3094–3106. 2008. View Article : Google Scholar
|
|
27
|
Hermanson M, Funa K, Hartman M,
Claesson-Welsh L, Heldin CH, Westermark B and Nistér M:
Platelet-derived growth factor and its receptors in human glioma
tissue: expression of messenger RNA and protein suggests the
presence of autocrine and paracrine loops. Cancer Res.
52:3213–3219. 1992.
|
|
28
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim Y, Kim E, Wu Q, et al:
Platelet-derived growth factor receptors differentially inform
intertumoral and intratumoral heterogeneity. Genes Dev.
26:1247–1262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Amantini C, Mosca M, Nabissi M, et al:
Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1
vanilloid receptor and requires p38 MAPK activation. J Neurochem.
102:977–990. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of β-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
|
|
33
|
Das A, Banik NL and Ray SK: Flavonoids
activated caspases for apoptosis in human glioblastoma T98G and
U87MG cells but not in human normal astrocytes. Cancer.
116:164–176. 2010.PubMed/NCBI
|
|
34
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu W, Lv G, Li Y, Li L and Wang B:
Downregulation of CDKN2A and suppression of cyclin D1 gene
expressions in malignant gliomas. J Exp Clin Cancer Res. 30:762011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng J, Kim ST, Liu W, et al: An
integrated analysis of germline and somatic, genetic and epigenetic
alterations at 9p21.3 in glioblastoma. Cancer. 118:232–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gabriely G, Yi M, Narayan RS, et al: Human
glioma growth is controlled by microRNA-10b. Cancer Res.
71:3563–3572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu C, Liu X, Wang Y, et al: Insulin-like
factor binding protein-3 promotes the G1 cell cycle arrest in
several cancer cell lines. Gene. 512:127–133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zi X, Guo Y, Simoneau AR, Hope C, Xie J,
Holcombe RF and Hoang BH: Expression of Frzb/secreted
Frizzled-related protein 3, a secreted Wnt antagonist, in human
androgen-independent prostate cancer PC-3 cells suppresses tumor
growth and cellular invasiveness. Cancer Res. 65:9762–9770. 2005.
View Article : Google Scholar
|
|
40
|
Tambe Y, Isono T, Haraguchi S,
Yoshioka-Yamashita A, Yutsudo M and Inoue H: A novel apoptotic
pathway induced by the drs tumor suppressor gene. Oncogene.
23:2977–2987. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li N, Jiang P, Du W, et al: Siva1
suppresses epithelial-mesenchymal transition and metastasis of
tumor cells by inhibiting stathmin and stabilizing microtubules.
Proc Natl Acad Sci USA. 108:12851–12856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mahesparan R, Tysnes BB, Read TA, Enger
PO, Bjerkvig R and Lund-Johansen M: Extracellular matrix-induced
cell migration from glioblastoma biopsy specimens in vitro. Acta
Neuropathol. 97:231–239. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fujita A, Sato JR, Festa F, et al:
Identification of COL6A1 as a differentially expressed gene
in human astrocytomas. Genet Mol Res. 7:371–378. 2008.
|
|
44
|
Wu A, Wei J, Kong LY, et al: Glioma cancer
stem cells induce immunosuppressive macrophages/microglia. Neuro
Oncol. 12:1113–1125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Roth P, Junker M, Tritschler I, et al:
GDF-15 contributes to proliferation and immune escape of malignant
gliomas. Clin Cancer Res. 16:3851–3859. 2010. View Article : Google Scholar : PubMed/NCBI
|
